-transparent.png){kind=logo}
The ProTide prodrug technology has proved very useful in the discovery of nucleotide therapeutics and has successfully led to two FDA-approved drugs. However, with the extensive application of this prodrug approach to nucleotides for nearly three decades, the intellectual property (IP) landscape is becoming congested and, to overcome this, new inventive applications of the ProTide prodrug technology are emerging.
| UI | MeSH Term | Description | Entries |
|---|
Related Publications
Ashwag S Alanazi, and
Edward James, and
Youcef Mehellou
March 2018,
Journal of medicinal chemistry,
Ashwag S Alanazi, and
Edward James, and
Youcef Mehellou
April 1967,
Medical services journal, Canada,
Ashwag S Alanazi, and
Edward James, and
Youcef Mehellou
October 2009,
Philosophical transactions of the Royal Society of London. Series B, Biological sciences,
Ashwag S Alanazi, and
Edward James, and
Youcef Mehellou
September 1897,
The Journal of comparative medicine and veterinary archives,
Ashwag S Alanazi, and
Edward James, and
Youcef Mehellou
September 2009,
Journal of medicinal chemistry,
Ashwag S Alanazi, and
Edward James, and
Youcef Mehellou
April 1983,
British journal of anaesthesia,
Ashwag S Alanazi, and
Edward James, and
Youcef Mehellou
October 2021,
Expert opinion on drug discovery,
Ashwag S Alanazi, and
Edward James, and
Youcef Mehellou
March 2005,
Emergency medical services,
Ashwag S Alanazi, and
Edward James, and
Youcef Mehellou
July 2014,
The British journal of general practice : the journal of the Royal College of General Practitioners,
